Cargando…

Increasing Compliance with Mass Drug Administration Programs for Lymphatic Filariasis in India through Education and Lymphedema Management Programs

BACKGROUND: Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India. India has faced challenges obtaining the needed levels of compliance with its mass drug administration (MDA) program to interrupt LF transmission, which utilizes diethylcarbamazine (DEC) or DEC plu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantey, Paul T., Rout, Jonathan, Rao, Grace, Williamson, John, Fox, LeAnne M.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900179/ https://www.ncbi.nlm.nih.gov/pubmed/20628595 http://dx.doi.org/10.1371/journal.pntd.0000728

Ejemplares similares

Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India
por: Stillwaggon, Eileen, et al.
Publicado: (2016)

Evaluating the Burden of Lymphedema Due to Lymphatic Filariasis in 2005 in Khurda District, Odisha State, India
por: Walsh, Victoria, et al.
Publicado: (2016)

Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program Volunteers
por: Cassidy, Tali, et al.
Publicado: (2016)

Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India
por: Sawers, Larry, et al.
Publicado: (2020)

Impact of Community-Based Lymphedema Management on Perceived Disability among Patients with Lymphatic Filariasis in Orissa State, India
por: Budge, Philip J., et al.
Publicado: (2013)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Coverage and Awareness of and Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis in Burdwan District, West Bengal, India
por: Roy, Rabindra Nath, et al.
Publicado: (2013)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination
por: Alexander, Neal D. E.
Publicado: (2015)

Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
por: Hussain, Mohammad A, et al.
Publicado: (2014)

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
por: Krentel, Alison, et al.
Publicado: (2013)

The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya
por: Njomo, Doris W., et al.
Publicado: (2012)

An Evaluation of Coverage and Compliance of Mass Drug Administration 2006 for Elimination of Lymphatic Filariasis in Endemic Areas of Gujarat
por: Kumar, Pradeep, et al.
Publicado: (2008)

Impact of a Community-Based Lymphedema Management Program on Episodes of Adenolymphangitis (ADLA) and Lymphedema Progression - Odisha State, India
por: Mues, Katherine E., et al.
Publicado: (2014)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Feasibility of school-based health education intervention to improve the compliance to mass drug administration for lymphatic Filariasis in Lalitpur district, Nepal: A mixed methods among students, teachers and health program manager
por: Karki, Prativa, et al.
Publicado: (2018)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation
por: Swaminathan, Subramanian, et al.
Publicado: (2012)

A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections
por: Campillo, Jérémy T., et al.
Publicado: (2021)

Coverage and compliance of mass drug administration in lymphatic filariasis amidst the COVID-19 pandemic: A community based epidemiological study
por: Chakraborty, Sumanta, et al.
Publicado: (2022)

What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs
por: Kastner, Randee J., et al.
Publicado: (2015)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

Comparison of Staging Systems to Assess Lymphedema Caused by Cancer Therapies, Lymphatic Filariasis, and Podoconiosis
por: Douglass, Janet, et al.
Publicado: (2019)

The Impact of the COVID-19 Pandemic on People With Lymphedema in an Endemic Area for Lymphatic Filariasis in Brazil
por: de Aquino, Lígia Tomaz, et al.
Publicado: (2023)

Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India
por: Ghosh, Santanu, et al.
Publicado: (2013)

Coverage of mass drug administration (MDA) and operational issues in elimination of lymphatic filariasis in selected districts of Jharkhand, India
por: Kumar, Dhananjay, et al.
Publicado: (2023)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

The development of a capacity-strengthening program to promote self-care practices among people with lymphatic filariasis-related lymphedema in the Upper West Region of Ghana
por: Atinbire, Solomon Abotiba, et al.
Publicado: (2021)

Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
por: Weerasooriya, Mirani V, et al.
Publicado: (2007)

Lot quality assurance sampling to assess coverage and compliance following mass drug administration to eliminate lymphatic filariasis in Fiji: A methodological approach
por: Rinamalo, Milika, et al.
Publicado: (2020)

Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection
por: Khan, Abdul Mabood
Publicado: (2018)

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study
por: Banerjee, Sitikantha, et al.
Publicado: (2019)

Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis
por: Pantelias, Anastasia, et al.
Publicado: (2022)

Mass Drug Administration Coverage Evaluation Survey for Lymphatic Filariasis in Bagalkot and Gulbarga Districts
por: Patel, Prakash Kurubarahalli
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kmsa3t97kojfoapv0l9qrpgrvs